language
Language
Englishchevron_right
attach_money
Currency
$USDchevron_right
dark_mode
Dark Mode
policy
Privacy Policy
gavel
Terms of Service
ACHCACHC

$16.88

-0.53
arrow_drop_down3.04%
Current Market·update13 Nov 2025 15:57
Day's Range
16.8-17.3
52-week Range
16.8-47.08

Chart

Loading chart...

Performance

Key Stats

Next Earnings Date2025-11-05
Next Earnings TimeAfter Market Close
Volume359.14K
Average Volume 30d2.76M

AI ACHC Summary

Powered by LiveAI
💰
18.4
Valuation (P/E Ratio)
Based on TTM data. Recent quarterly P/E ratios are higher but show volatility.
📈
0.152
EPS Growth (YoY)
Calculated from 2023Q4 net income (-$21.67M) to 2024Q4 net income ($255.61M). Note the significant turnaround from a loss.
Show More 🔒

AI Scoreboard

Powered by LiveAI
🔒

Overall Analysis

Buy
72

Acadia Healthcare shows strong fundamental performance with solid profitability and a manageable debt level. Thematic tailwinds in behavioral health are supportive, but recent technical indicators suggest a cautious approach due to a mixed short-term outlook. Recommended for investors seeking long-term exposure to the healthcare sector.

Strong

Thematic

75

Acadia Healthcare is well-positioned to benefit from increasing demand for behavioral healthcare services, driven by rising awareness of mental health issues and expanding access to care.

Strong

Fundamental

78

Acadia Healthcare demonstrates robust financial health with consistent revenue growth and improving profitability, supported by a stable balance sheet. Diligence in managing debt and a focus on operational efficiency are key strengths.

Neutral

Technical

60

Acadia Healthcare's stock is trading within a range, showing mixed signals across different timeframes. While some moving averages suggest an upward trend, oscillators indicate a neutral to cautionary stance, suggesting potential consolidation.

FactorScore
Behavioral Health Demand85
Reimbursement Landscape70
Market Penetration & Expansion75
Competitive Landscape65
FactorScore
Valuation85
Profitability80
Growth75
Balance Sheet Health80
Cash Flow70
FactorScore
Trend Analysis70
Momentum50
Volume Confirmation65
Support & Resistance55

AI Investing Checklist

Powered by LiveAI
thumb_up

Bullish Points (5)

Earnings Performance chevron_right

Improving Earnings

The company has shown positive earnings surprises in the last two reported quarters (2024 Q4 and 2024 Q3), indicating potential for better-than-expected performance.

Valuation chevron_right

Reasonable P/E Ratio

The trailing P/E ratio of 18.4 for the TTM period and 14.3 for the fiscal year 2024 are within a reasonable range for the industry, suggesting the stock may not be excessively overvalued based on current earnings.

Show More 🔒
thumb_down

Bearish Points (7)

Valuation Risk chevron_right

High Quarterly P/S Ratio

The quarterly P/S ratio for 2025 Q1 is 3.6, and for 2024 Q4 is 4.7, which are relatively high compared to the TTM P/S of 0.8, suggesting potential overvaluation based on recent sales trends.

Growth Deceleration chevron_right

Negative Revenue Growth in Latest Quarter

While fiscal year 2024 revenue grew, the quarterly revenue for 2025 Q1 ($770.5 million) and 2024 Q4 ($774.2 million) shows a slowdown and potential decline compared to previous quarters.

Show More 🔒

Calendar

August 2025

6

Next Earnings Date

EPS Est.
Revenue Est.

H: $0.85

A: $0.71

L: $0.53

H: 860.75M

A: 841.00M

L: 825.00M

Profile

Employees (FY)25.5K
ISIN-
FIGI-

Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

Seasonals

2025
2024
2023
2022
2021

Price Target

41.86 USD

The 39 analysts offering 1 year price forecasts for ACHC have a max estimate of 66.00 and a min estimate of 28.00.

Debt Level and Coverage

Debt
Free cash flow
Cash & equivalents

Financial Position Analysis

Assets
Liabilities

Ownership

Free Float shares
90.4M (98.14%)
Closely held shares
1.72M (1.86%)
92.1M
Free Float shares
90.4M (98.14%)
Closely held shares
1.72M (1.86%)

Capital Structure

Market cap
2B
Debt
2.09B
Minority interest
0.00
Cash & equivalents
76.31M
Enterprise value
4.01B

Valuation - Summary

Market Cap
2B
Net income
109M(5.45%)
Revenue
2.36B(117.86%)
2B
Market Cap
2B
Net income
109M(5.45%)
Revenue
2.36B(117.86%)
Price to earning ratio (P/E)18.40x
Price to sales ratio (P/S)0.80x

Valuation - Ratios

P/E
P/S

Revenue to Profit Conversion

Revenue
3.15B
COGS
112.71M
Gross Profit
3.04B
OpEx
2.52B
Operating Income
522.28M
Other & Taxes
266.66M
Net Income
255.61M

Balance Sheet

Total assets
Total liabilities
Liabilities to assets %

Income Statement

Revenue
Net Income
Net Margin

Cash Flow

Operating Cash Flow
Investing Cash Flow
Financing Cash Flow
Show More 🔒